Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Avmapki Fakzynja Co-Pack
Verastem, Inc.
Avmapki Fakzynja Co-Pack
(avutometinib; defactinib)Orphan drugacceleratedVerastem, Inc.
12.1 Mechanism of Action Avutometinib Avutometinib is a MEK1 inhibitor. Avutometinib induces the formation of inactive RAF/MEK complexes and prevents ...
Browse all Hereditary site-specific ovarian cancer syndrome news →
Elizabeth Fox, MD
National Cancer Institute (NCI)
Anna Pawlowska, MD, MD
City of Hope Medical Center
📍 DUARTE, CA
Elizabeth C. Dees, MD, MD
UNC Lineberger Comprehensive Cancer Center
📍 CHAPEL HILL, NC
Kenneth G. Lucas, MD
Milton S. Hershey Medical Center
Hillard M. Lazarus, MD, MD
Ireland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center
📍 CLEVELAND, OH
Robert Z. Orlowski, MD, PhD, MD
UNC Lineberger Comprehensive Cancer Center
📍 HOUSTON, TX
View all Hereditary site-specific ovarian cancer syndrome specialists →